Payments stocks react to Covid-19 vaccine

Payments stocks react to Covid-19 vaccine

Monday 9 November saw significant stock market moves following the news that a Covid-19 vaccine candidate developed by Pfizer and BioNTech was 90% effective in interim clinical trial results. How did the news impact the payments world?

payments stocks covid-19 vaccine

For companies that have benefited from lockdown, such as Peloton, Zoom and Netflix, this led to stark drops, but for payments companies it has been a story of two halves.

While those serving travel, consumer and B2B cross-border payments have seen their value surge on the prospect of international travel (and life) returning to normal, ecommerce companies saw their values drop as investors anticipated a slump in online spending. 

Of course, these are just interim results for a vaccine that still has to undergo several regulatory and manufacturing steps. However, it does provide a sense of how the market may adjust post-pandemic. 

Read More About

Nuvei goes private: Inside the Advent International deal

April 11th, 2024

Stripe’s changing valuation

March 8th, 2024

How have cross-border payments stocks performed in 2023?

December 8th, 2023

Sign In
Account Registration
By creating an account, you agree to our
Terms and Conditions
Please enter your email address
We'll send you instructions on how to reset your password.